| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Property, plant and equipment, net | 381,048 | |||
| Available-for-sale securities, at fair value | 770,579 | |||
| Prepaid expenses | 23,692 | |||
| Other current assets | 13,160 | |||
| Cash, cash equivalents and restricted cash | 129,793 | |||
| Accounts receivable | 9,699 | |||
| Total current assets | 946,923 | |||
| Intangible assets, net | 7,286 | |||
| Other assets | 1,353 | |||
| Right-of-use assets | 44,002 | |||
| Total assets | 1,380,612 | |||
| Accrued expenses | 64,818 | |||
| Other liabilities | 7,375 | |||
| Lease liabilities | 7,010 | |||
| Credit facility | 40,000 | |||
| Accrued payroll and benefits | 19,298 | |||
| Deferred revenue | 22,979 | |||
| Accounts payable | 33,050 | |||
| Total current liabilities | 194,530 | |||
| Accumulated deficit | -1,603,404 | |||
| Common stock, 0.001 par value authorized 290,000 shares issued and outstanding 138,144 and 124,376 shares | 230 | |||
| Additional paid-in capital | 2,120,130 | |||
| Accumulated other comprehensive income | 5,357 | |||
| Stockholders equity | 522,313 | |||
| Noncontrolling interest | -2,507 | |||
| Total noncontrolling interest and stockholders equity | 519,806 | |||
| Lease liabilities, net of current portion | 105,690 | |||
| Credit facility, net of current portion | 200,332 | |||
| Liability related to the sale of future royalties | 360,254 | |||
| Total long-term liabilities | 666,276 | |||
| Total liabilities, noncontrolling interest and stockholders equity | 1,380,612 | |||
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)